Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Vaccine

• Publication date

  1999-08-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(99)00167-XPMID 10462227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal antibody responses in patients with persistent generalized lymphadenopathy

  2004cited by this paper
• Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.

  1999cited by this paper
• Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.

  1996cited by this paper
• The effects of immunization in human immunodeficiency virus type 1 infection.

  1996cited by this paper
• The effects of immunization in human immunodeficiency virus type 1 infection.

  1996cited by this paper
• T cell-independent antigens type 2.

  1995cited by this paper
• Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients.

  1995cited by this paper
• The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital.

  1995cited by this paper
• Bacterial enteric infections in persons infected with human immunodeficiency virus.

  1995cited by this paper
• Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.

  1994cited by this paper
• Defective IgG2 response to Pneumovax in HIV seropositive patients.

  1993cited by this paper
• Intestinal antibody responses to oral vaccination in HIV‐infected individuals

  1993cited by this paper
• Thymus-independent and thymus-dependent responses to polysaccharide antigens.

  1992cited by this paper
• Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine.

  1992cited by this paper
• Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area.

  1991cited by this paper
• Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV‐infected patients

  1991cited by this paper
• Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus.

  1989cited by this paper
• Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

  1988cited by this paper
• Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection.

  1987cited by this paper
• Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

  1987cited by this paper
• Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

  1987cited by this paper
• Incidence of salmonellosis in patients with AIDS.

  1987cited by this paper
• Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

  1987cited by this paper
• Salmonellosis during infection with human immunodeficiency virus.

  1987cited by this paper
• Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

  1987cited by this paper
• Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome.

  1986cited by this paper
• Salmonella infections in patients with the acquired immunodeficiency syndrome.

  1985cited by this paper
• Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome.

  1985cited by this paper
• Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome.

  1985cited by this paper
• B-cell immunodeficiency in acquired immune deficiency syndrome.

  1984cited by this paper
• Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

  1984cited by this paper
• Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

  1983cited by this paper
• Purification and immunochemical properties of Escherichia coli B polysaccharide cross-reacting with Salmonella typhi Vi antigen: preliminary evidence for cross-reaction of the polysaccharide with Escherichia coli K1 antigen

  1983cited by this paper
• Thymus-independent antigens: complexity of B-lymphocyte activation revealed.

  1982cited by this paper
• Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

  1977cited by this paper
• The Theory of the‘One Nonspecific Signal’Model for B Cell Activation

  1975cited by this paper
• Studies on Vi antigen. II. Purification of Vi antigen from Escherichia coli 5395/38.

  1952cited by this paper

• Infection prevention in the immunocompromised traveler due to conditions other than transplantation: a review

  2025cites this paper
• Inflammation and Microbial Translocation Correlate with Reduced MAIT Cells in People with HIV

  2024cites this paper
• A dynamical model for HIV-typhoid co-infection with typhoid vaccine

  2021cites this paper
• Typhoid fever infection - antibiotic resistance and vaccination strategies: a narrative review.

  2020cites this paper
• Travel vaccination recommendations and infection risk in HIV-positive travellers.

  2019cites this paper
• 71 – Vaccines for International Travel

  2018cites this paper
• Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.

  2018cites this paper
• Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II

  2017cites this paper
• Travel Medicine, Vaccines, and Transplant Tourism

  2016cites this paper
• Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection

  2016cites this paper
• British HIV Association Guidelines on the Use of Vaccines in HIV‐Positive Adults 2015

  2016cites this paper
• Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures

  2015cites this paper
• Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques

  2015cites this paper
• Vaccination in HIV-Infected Adults

  2014cites this paper
• International travel patterns and travel risks of patients diagnosed with cancer.

  2013cites this paper
• 65 – Vaccines for international travel

  2013cites this paper
• Vaccination in HIV-infected individuals

  2012cites this paper
• Vi antigen of Salmonella enetrica serovar Typhi — biosynthesis, regulation and its use as vaccine candidate

  2012cites this paper
• Vaccines and Passive Immunity against Candidiasis

  2012cites this paper
• memory during HIV-1 infection Loss of memory B cells impairs maintenance of long-term serological

  2012cites this paper
• Development of a vaccine against Staphylococcus aureus

  2011cites this paper
• Development of a Bead Immunoassay To Measure Vi Polysaccharide-Specific Serum IgG after Vaccination with the Salmonella enterica Serovar Typhi Vi Polysaccharide

  2010cites this paper
• Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy.

  2010cites this paper
• Evolution of the human immunodeficiency virus type 1 envelope glycoprotein during chronic infection

  2010cites this paper
• Dispositional optimism and stress-induced changes in immunity and negative mood

  2009cites this paper
• Genetic determinants of immune-response to a polysaccharide vaccine for typhoid

  2009cites this paper
• Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?

  2009cites this paper
• Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.

  2009cites this paper
• [Vaccinations of HIV-infected travelers].

  2009cites this paper
• Vaccination and immunization against travel-related diseases in immunocompromised hosts

  2008cites this paper
• HIV-1 infection and loss of serological memory : The role of altered expression of B-cell chemokine receptors, timing of HAART and impaired antibody affinity maturation

  2008cites this paper
• Revue générale Vaccinations du voyageur infecté par le VIH Vaccinations of HIV-infected travelers

  2008cites this paper
• B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

  2008cites this paper
• British HIV Association guidelines for immunization of HIV‐infected adults 2008

  2008cites this paper
• The HIV-positive traveler.

  2007cites this paper
• Immunization of the HIV infected traveller.

  2007cites this paper
• Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.

  2007cites this paper
• Committee to Advise on Tropical Medicine

  2007cites this paper
• Vaccination in patients with HIV infection

  2006cites this paper
• Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

  2006cites this paper
• Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers

  2005influential citation
• Prevention of Infection in Adult Travelers After Solid Organ Transplantation

  2005cites this paper
• Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity

  2005cites this paper
• B lymphocyte dysfunctions in HIV infection.

  2004cites this paper
• Immunization for persons infected with human immunodeficiency virus.

  2004cites this paper
• Immunological Response in HIV-Positive Patients Vaccinated against Tick-Borne Encephalitis

  2003cites this paper
• [Vaccination and infection protection in patients with acquired or congenital immunodeficiency].

  2001cites this paper
• Efficient vaccination strategy against typhoid fever.

  2000cites this paper